• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

地塞米松玻璃体内植入剂(Ozurdex)治疗儿童非感染性中间葡萄膜炎及相关囊样黄斑水肿:6 个月随访时的黄斑形态和功能评估;MfERG 的更深层次作用?

Dexamethasone Intravitreal Implant (Ozurdex) in Paediatric Patients with Non-infectious Intermediate Uveitis and Related Cystoid Macular Oedema: Evaluation of Macular Morphology and Function with Six-month Follow-up; a Deeper Role of MfERG?

机构信息

Ophthalmology Department, Bambino Gesù Children's Hospital, IRCCS, Rome, Italy.

出版信息

Ocul Immunol Inflamm. 2022 Jan 2;30(1):234-240. doi: 10.1080/09273948.2020.1794011. Epub 2020 Aug 24.

DOI:10.1080/09273948.2020.1794011
PMID:32835577
Abstract

PURPOSE

To evaluate the efficacy of Ozurdex implant by analyzing macular morphology and function in pediatric uveitis and related cystoid macular edema (CMO).

METHODS

Main outcomes were visual acuity, mfERG and photopic ERG response, and central macular thickness. Mean values recorded at each time-point were compared to baseline and correlations between functional and anatomical parameters were evaluated.

RESULTS

Resolution of intraocular inflammation and CMO was achieved in all eyes 1 month after implant without procedure or drug-related complications. Mean visual acuity and mfERG amplitude improved showing a statistically significant difference to baseline values for the first 4 months. Mean central macular thickness showed a statistically significant reduction for all follow-up time. Photopic ERG did not vary significantly. Statistically significant correlation was found between trends of visual acuity, central macular thickness, and mfERG responses.

CONCLUSION

Correlation found between macular morphology and function confirms the efficacy of Ozurdex in pediatric uveitis.

摘要

目的

通过分析小儿葡萄膜炎及相关囊样黄斑水肿(CMO)的黄斑形态和功能,评估 Ozurdex 植入物的疗效。

方法

主要观察指标为视力、mfERG 和明视 ERG 反应以及中心黄斑厚度。在每个时间点记录的平均值与基线进行比较,并评估功能和解剖参数之间的相关性。

结果

植入后 1 个月,所有眼均实现了眼内炎症和 CMO 的消退,无手术或药物相关并发症。平均视力和 mfERG 振幅在头 4 个月内均有显著改善,与基线值相比具有统计学意义。所有随访时间的平均中央黄斑厚度均有显著降低。明视 ERG 无显著变化。视力、中央黄斑厚度和 mfERG 反应的趋势之间存在显著相关性。

结论

黄斑形态和功能之间的相关性证实了 Ozurdex 在小儿葡萄膜炎中的疗效。

相似文献

1
Dexamethasone Intravitreal Implant (Ozurdex) in Paediatric Patients with Non-infectious Intermediate Uveitis and Related Cystoid Macular Oedema: Evaluation of Macular Morphology and Function with Six-month Follow-up; a Deeper Role of MfERG?地塞米松玻璃体内植入剂(Ozurdex)治疗儿童非感染性中间葡萄膜炎及相关囊样黄斑水肿:6 个月随访时的黄斑形态和功能评估;MfERG 的更深层次作用?
Ocul Immunol Inflamm. 2022 Jan 2;30(1):234-240. doi: 10.1080/09273948.2020.1794011. Epub 2020 Aug 24.
2
Efficacy of Ozurdex implant in treatment of noninfectious intermediate uveitis.Ozurdex植入物治疗非感染性中间葡萄膜炎的疗效
Indian J Ophthalmol. 2015 Oct;63(10):767-70. doi: 10.4103/0301-4738.171505.
3
An Experience with Intravitreal Dexamethasone Implant for Uveitic Macular Oedema.玻璃体内注射地塞米松植入物治疗葡萄膜炎性黄斑水肿的体验。
J Nepal Health Res Counc. 2021 Dec 15;19(3):647-649. doi: 10.33314/jnhrc.v19i3.2292.
4
[Tolerability and short-term efficacy of the Ozurdex® dexamethasone intravitreal implant for treatment of uveitic cystoid macular edema: A retrospective study of 52 injections performed at the Clermont-Ferrand teaching hospital].Ozurdex®地塞米松玻璃体内植入物治疗葡萄膜炎性黄斑囊样水肿的耐受性和短期疗效:对克莱蒙费朗教学医院进行的52次注射的回顾性研究
J Fr Ophtalmol. 2016 Jan;39(1):1-4. doi: 10.1016/j.jfo.2015.07.009. Epub 2015 Nov 23.
5
The Efficacy and Safety of Intravitreal Dexamethasone Implant as Anti-inflammatory Monotherapy in the Management of Tuberculosis-associated Intermediate Uveitis.玻璃体内注射地塞米松植入物作为抗炎症单药疗法治疗结核相关性中间葡萄膜炎的疗效和安全性。
Ocul Immunol Inflamm. 2023 Oct;31(8):1594-1602. doi: 10.1080/09273948.2021.1986544. Epub 2021 Oct 12.
6
Dexamethasone intravitreal implant (Ozurdex®) for pediatric uveitis.用于儿童葡萄膜炎的地塞米松玻璃体内植入剂(Ozurdex®)
Graefes Arch Clin Exp Ophthalmol. 2015 Oct;253(10):1777-82. doi: 10.1007/s00417-015-3124-x. Epub 2015 Jul 31.
7
Intravitreal dexamethasone implants for non-infectious uveitis.玻璃体内注射地塞米松植入物治疗非感染性葡萄膜炎。
Clin Exp Ophthalmol. 2019 Dec;47(9):1156-1163. doi: 10.1111/ceo.13611. Epub 2019 Aug 27.
8
[Dexamethason implant in the treatment of macular edema in retinal vein occlusion and intraocular inflammatory disease].[地塞米松植入物治疗视网膜静脉阻塞和眼内炎性疾病中的黄斑水肿]
Klin Monbl Augenheilkd. 2013 Apr;230(4):396-400. doi: 10.1055/s-0032-1328365. Epub 2013 Apr 29.
9
[Efficacy of a Dexamethasone Implant for the Treatment of Refractory Cystoid Macular Oedema in Non-Infectious Uveitis].[地塞米松植入物治疗非感染性葡萄膜炎所致难治性黄斑囊样水肿的疗效]
Klin Monbl Augenheilkd. 2016 May;233(5):601-5. doi: 10.1055/s-0042-102058. Epub 2016 May 17.
10
Spectral domain optical coherence tomography changes following intravitreal dexamethasone implant, Ozurdex® in patients with uveitic cystoid macular edema.玻璃体内注射地塞米松植入剂Ozurdex®治疗葡萄膜炎性黄斑囊样水肿患者后,频域光学相干断层扫描的变化
Indian J Ophthalmol. 2015 May;63(5):416-22. doi: 10.4103/0301-4738.159870.

引用本文的文献

1
Case report: Ultrasound biomicroscopy as a guide for the selection of injection sites for dexamethasone intravitreal implant (Ozurdex) for peripheral granulomatous ocular toxocariasis in children.病例报告:超声生物显微镜引导下为儿童周边肉芽肿性眼弓蛔虫病患者选择地塞米松玻璃体内植入剂(Ozurdex)的注射部位
Front Med (Lausanne). 2023 May 16;10:1176585. doi: 10.3389/fmed.2023.1176585. eCollection 2023.
2
Sympathetic ophthalmia after vitreoretinal surgery: a report of two cases.玻璃体积血视网膜手术后交感性眼炎:两例报告。
J Int Med Res. 2021 Aug;49(8):3000605211032782. doi: 10.1177/03000605211032782.